Here are relevant reports on : AI-in-Radiology-Market
-
Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029
The global advanced visualization market, valued at US$3.36 billion in 2023, stood at US$3.78 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$6.55 billion by the end of the period. Technological advancements in advanced visualization tools, the rising need for early detection of diseases, and the growing support from government & private organizations are key factors driving the market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Elastography Imaging Market by Modality (Ultrasound, Magnetic Resonance Elastography), Application (Radiology, Cardiology, OB/GYN, Vascular, Orthopedic and Musculoskeletal), End User (Hospital, Surgery Center, Diagnostic Center) - Global Forecast to 2024
The Elastography Imaging Market is projected to reach USD 4.6 billion by 2024, growing at a CAGR of 11.0 %. The growth of this market is mainly driven by the growing incidence of breast cancer and chronic liver diseases and a rising preference for minimally invasive procedures across the globe. However, the high cost of elastography imaging systems and an unfavorable reimbursement scenario are expected to restrain the growth of this market to a certain extent.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Products Market Size, Share & Trends by type (Stents, Catheters, IVC Filter, Biopsy Needles, Embolization Devices, Accessories), Procedure Type (Angioplasty, Angiography, Thrombolysis, Embolization), Applications (Oncology) - Global Forecast to 2026
The size of global interventional radiology products market in terms of revenue was estimated to be worth USD 10.2 billion in 2021 and is poised to reach USD 14.1 billion by 2026, growing at a CAGR of 6.6% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Medical Coding Market by Offering (Software, Outsourcing Services), Classification (ICD, CPT, HCPCS), Specialty (Surgical, Radiology), Function (Code, Assignment, Reimbursement, Analytics, Denial, Audit), End User (Healthcare Providers, Healthcare Payers) - Global Forecast to 2030
The global Medical Coding market, valued at US$8.18 billion in 2024, stood at US$8.91 billion in 2025 and is projected to advance at a resilient CAGR of 9.5% from 2025 to 2030, culminating in a forecasted valuation of US$14.01 billion by the end of the period. The market is growing steadily, driven by the rising volume of healthcare services, increasing adoption of electronic health records (EHRs), and the need for accurate billing and reimbursement.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Digital X-Ray Market by Technology (Direct, Computed Radiography), System (Retrofit, New), Portability (Fixed, Portable), Application (General Radiology, Dental, Mammography, Cancer, Fluoroscopy), End User, & Price Range - Forecast to 2031
The Asia Pacific digital X-ray market is projected to reach USD 1.86 billion by 2031, growing at a CAGR of 6.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Dental Diagnostic & Surgical Equipment Market - (Radiology, Laser, CAD/CAM Devices & Chairs) – Current Trends, Opportunities and Global Forecasts (2011 - 2016)
The market for dental diagnostic and surgical equipment consists of devices used in diagnosing dental diseases/conditions and treating the same. These include dental chairs, hand pieces, CAD/CAM systems, scaling units, instrument delivery systems, dental lasers, intra oral and extra oral radiology equipment, and CBCT scanners. The global market for these equipments was valued at $4.5 billion in 2011 and is expected to grow at a CAGR of 5.8% from 2011-2016.
- Published: March 2012
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Imaging Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021
The global interventional radiology imaging market is projected to grow at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) & Region - Global Forecast to 2026
The global vascular closure devices market growth is primed to transition from $0.9 billion in 2021 to $1.3 billion by 2026, showcasing a strong CAGR of 7.0%. The growth in this market can be attributed to the large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, increasing prevalence of obesity, increasing focus of market players on large-bore vascular closure devices, growing geriatric population, favorable reimbursement scenario for interventional radiology procedures, and rising focus on effective blood loss management in patients during surgeries.
- Published: October 2021
- Price: $ 4950
- TOC Available:
-
Inflation Device Market by Display Type (Analog & Digital), Capacity (20ml, 30ml, 60ml), Application (Interventional Cardiology, Radiology, Peripheral Vascular, Urology), End User (Hospitals & Clinics, Ambulatory Surgery Centers) - Forecasts to 2024
The inflation device market is projected to reach USD 600 Million by 2024, at a CAGR of 4.7%. The rising adoption of minimally invasive procedures, the presence of developed healthcare infrastructure in a majority of developed countries, the growing incidence of CVD, and the less-stringent approval procedures are contributing to the growth of the market. With the growth of the geriatric population, the prevalence of coronary artery disease is also expected to increase, which is a major target indication for interventional cardiology procedures that utilizes inflation devices to inflate and deflate the balloon. Aforementioned key factors are likely to fuel growth of inflation devices market over the forecast period. The major players operating in the inflation devices market are Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
